R. Mark Graf - 14 May 2026 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Reporting relationship: Director
Issuer ticker: HRMY
Reported as of: 14 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 May 2026, 16:18:03 UTC
Prior SEC filing: 23 Feb 2026
Next SEC filing: 26 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Christian Ulrich, Attorney-in-Fact

Key filing fact

R. Mark Graf filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 18 May 2026.

Key facts

This page summarizes R. Mark Graf's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 May 2026, 16:18.

Change

Previous filing in this sequence was filed on 23 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001494757 Primary reporting owner

Graf R. Mark

Relationship: Director
Address: C/O HARMONY BIOSCIENCES HOLDINGS, INC., 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING
Signature: /s/ Christian Ulrich, Attorney-in-Fact
Signature date: 18 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRMY transaction Derivative

Stock Option

Award

Transaction value
Shares: +21,872
Change %
Price: $0.000000^*
Shares after: 21,872
Date: 14 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,872
Exercise price: $30.76
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.